Go to Member Homepage
Go to Submission Portal
Forgot your USERNAME OR PASSWORD?
Find us on the popular social networks
The Division for Drug Discovery and Development (DDD) serves to help its members teach, present and discuss the critical role of pharmacology in all phases of the drug discovery, development and registration process. The process encompasses, but is not limited to; target discovery and validation, medicinal chemistry, combinatorial chemistry, molecular modeling and drug design, structure-pharmacological function relationships, functional genomics and proteomics, high throughput screening, identification and development of natural products, nutraceuticals, pharmacokinetics and pharmacodynamics, clinical testing and drug regulation/registration, clinical contracting and pharmacoepidemiology and pharmacoeconomics.
The 2017 ASPET election closed on February 10, 2017 with a great turnout. Congratulations to the new Council members, division chairs, and division secretary-treasurers.
The ASPET Annual Meeting site has all the details on division meetings and activities, including the business meeting for each division. Agendas are now available for download for the business meetings.
Dr. Timothy A. Esbenshade, Project Director/Sr. Principal Research Scientist, Global Research and Development, AbbVie has been elected chair-elect of the division. Dr. Tom J. Parry, Senior Director, Pharmacology and Safety, Research and Development, Acorda Therapeutics, Inc. has been elected secretary/treasurer-elect of the division.
©The American Society for Pharmacology and Experimental Therapeutics (ASPET)9650 Rockville Pike, Bethesda, Maryland 20814-3995
ASPET.org is best viewed with Internet Explorer 7+, Firefox 3.5+ and Safari 3+.